"10.1371_journal.pone.0124314","plos one","2015-04-08T00:00:00Z","Hirotoshi Watanabe; Takeshi Morimoto; Masahiro Natsuaki; Yutaka Furukawa; Yoshihisa Nakagawa; Kazushige Kadota; Kyohei Yamaji; Kenji Ando; Satoshi Shizuta; Hiroki Shiomi; Tomohisa Tada; Junichi Tazaki; Yoshihiro Kato; Mamoru Hayano; Mitsuru Abe; Takashi Tamura; Manabu Shirotani; Shinji Miki; Mitsuo Matsuda; Mamoru Takahashi; Katsuhisa Ishii; Masaru Tanaka; Takeshi Aoyama; Osamu Doi; Ryuichi Hattori; Masayuki Kato; Satoru Suwa; Akinori Takizawa; Yoshiki Takatsu; Eiji Shinoda; Hiroshi Eizawa; Teruki Takeda; Jong-Dae Lee; Moriaki Inoko; Hisao Ogawa; Shuichi Hamasaki; Minoru Horie; Ryuji Nohara; Hirofumi Kambara; Hisayoshi Fujiwara; Kazuaki Mitsudo; Masakiyo Nobuyoshi; Toru Kita; Adnan Kastrati; Takeshi Kimura; CREDO-Kyoto PCI/CABG registry cohort-2 investigators","Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Division of Genera Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan; Division of Cardiology, Tenri Hospital, Tenri, Japan; Division of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan; Division of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan; Division of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Division of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan; Division of Cardiology, Nara Hospital, Kinki University Faculty of Medicine, Nara, Japan; Division of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan; Division of Cardiology, Kishiwada City Hospital, Kishiwada, Japan; Division of Cardiology, Shimabara Hospital, Kyoto, Japan; Division of Cardiology, Kansai Electric Power Hospital, Osaka, Japan; Division of Cardiology, Osaka Red Cross Hospital, Osaka, Japan; Division of Cardiology, Shimada Municipal Hospital, Shimada, Japan; Division of Cardiology, Shizuoka General Hospital, Shizuoka, Japan; Division of Cardiology, Maizuru Kyosai Hospital, Maizuru, Japan; Division of Cardiology, Juntendo University Shizuoka Hospital, Shizuoka, Japan; Division of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan; Division of Cardiology, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Japan; Division of Cardiology, Hamamatsu Rosai Hospital, Hamamatsu, Japan; Division of Cardiology, Nishi-Kobe Medical Center, Kobe, Japan; Division of Cardiology, Koto Memorial Hospital, Higashioumi, Japan; Division of Cardiology, University of Fukui Hospital, Fukui, Japan; Cardiovascular Center, the Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan; Department of Cardiovascular and Respiratory, Shiga University of Medical Science, Otsu, Japan; Division of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan; Deutsches Herzzentrum, Munich, Germany","Conceived and designed the experiments: HW TM M. Natsuaki YF T. Kimura. Analyzed the data: HW TM. Contributed reagents/materials/analysis tools: HW TM. Wrote the paper: HW TM T. Kimura. Acquisition of data: M. Natsuaki HS T. Tada JT YK M. Hayano MA. Analysis and interpretation of data: M. Natsuaki HS T. Tada JT YK M. Hayano MA. Critical revision of the manuscript for important intellectual content: YN KK KY KA S. Shizuta T. Tamura MS SM MM M. Takahashi KI M. Tanaka TA OD RH MK S. Suwa AT YT ES HE T. Takeda JDL MI HO SH M. Horie RN HK HF KM M. Nobuyoshi T. Kita AK. Study supervision: TM YF T. Kimura.","TK (T. Kimura) is an advisory board member of Terumo Japan and Abbott Vascular. HO received research support from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Kowa, Mitsubishi Tanabe, MSD, Novartis, Otsuka, Pfizer, Sanofi, Sionogi, Takeda, and received honoraria from Daiichi Sankyo, MSD, Sanofi, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Chugai, Dainippon Sumitomo Pharma, Eisai, Kowa, Kyowa Hakko Kirin, Mitsubishi Tanabe, Mochida, Novartis, Otsuka, Pfizer, Sionogi, Takeda. AK received honoraria for lectures and event adjudication from Abbott, Astra-Zeneca, Biosensors, Biotronic, MSD, The Medicines, and St. Jude Medical. No other authors reported disclosures. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","04","Hirotoshi Watanabe","HW",46,TRUE,3,NA,2,3,TRUE,TRUE,TRUE,11,"13;21;24;25;31;33;35;38;39;40;44",TRUE
